Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

FRCR2 > endometrium > Flashcards

endometrium Flashcards

1
Q

What are the endometrial cancer histologies

A

Endometrioid adenocarcinoma
Clear cell
Papillary serous
Carcinosarcoma (tx as high grade endometrial adenoca)
Leiomyosarcoma / endometrial stromal sarcoma - treat as sarcoma
Squamous, small cell, lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the risk factors for endometrial cancer

A

Oestrogen exposure - oestrogen only HRT, PCOS, obesity, nulliparity, increasing years of menstruation
Previous breast cancer

Genetic factors - Lynch type II

Atypical endometrial hyperplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the endometrial management of Lynch syndrome

A

Yearly TV USS from 35yrs, prophylactic H+BSO from 40

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the frequency of concurrent ovarian and endometrial carcinoma

A

8%
If histologies match - treat as endometrial that has spread to the ovary
If different histology = two primaries, and treat highest stage first

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the molecular subgroups of endometrial carcinoma

A

EC - POLE mut
EC - dMMR
EC - pMMR, p53 mut - poorest outcome, and greatest benefit from chemo
EC - pMMR, p53 WT - NSMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How often are POL-E mutations seen in endometrial cancer
What is the consequence

A

10%
High mutational burden and typically have better outcomes
Can consider de-escalating treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the four proteins tested for in Lynch syndrome

A

PMS2, MSH6, MSH2, MLH1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What proportion of endometrial cancers (incl dMMR) are related to Lynch syndrome

A

3% of endometrial cancers and 10% of dMMR ECs are related to Lynch syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When is the endometrium thickness abnormal

A

> 3mm if post menopausal and not on HRT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is endometrial cancer investigated

A

TV USS + hysteroscopy & biopsy
MRI pelvis
Staging CT
+/- PET
+/- cystoscopy / sigmoidoscopy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What surgery should be done in a Stage 1 serous EC & carcinosarcoma

A

TAH & BSO, with omentectomy, peritoneal biopsy and LN staging (behaves like ovarian)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When should LN evaluation take place for endometrial cancer

A

≥Gr3, ≥FIGO IB, non-endometrioid histology,
SNLB or sentinel lymphadenectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How can fertility be spared for a stage 1 endometrial cancer

A

Gr1 stage 1A only
Ovary sparing TAH

Or mirena coil and oral progesterone

Monitor closely - repeat endometrial biopsy at 3 & 9 months.
Hysteroscopy 6 & 12 months.
After 1 year, if CR, can have fertility treatment, followed by complete hysterectomy (discussion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the management of a stage one endometrial cancer

A

TAH + BSO unless PM and Gr1 stage 1A and fertility sparing is desired

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the management of a stage 2 endometrial cancer

A

TAH + BSO + pelvic lymphadenectomy
+ omentectomy if serous histology (behaves like ovarian)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the management of a stage 3 endometrial cancer

A

TAH + BSO + lymphadenectomy
Adj tx

17
Q

What is the management of a stage 4 endometrial cancer

A

Operable - consider exenteration & adjuvant treatment

Inoperable - NACT, EBRT (45Gy/25# & boost to macroscopic disease), +/- surgery if disease becomes operable

18
Q

What is the benefit of adjuvant RT for endometrial cancer

A

10% improvement in local recurrence risk
No improvement in overall survival

19
Q

How is a low risk endometrial cancer defined in the adjuvant setting

what adj tx needed

A

Stage 1A, endometriod, gr1-2, LVSI negative or focal
Or stage 1-3 and POLE-mut

no adj tx indicated

20
Q

How is an intermediate risk endometrial cancer defined

what tx

A

All LVSI negative or focal

Stage 1B, gr1-2, endometriod
Stage 1A, gr3, endometrioid
Stage 1A, non-endometrioid histology, any grade (no adj tx)
Stage 2, gr1, endometrioid
Stage 1A, p53 abn (still tx with adj EBRT)

Adjuvant treatment: Vaginal brachytherapy
Can consider omitting if age >60

No adj tx if stage 1A non-endometrioid

21
Q

How is high-intermediate risk endometrial cancer defined

A

All endometrioid
Stage 1, high LVSI
Stage 1B, grade 3, any LVSI status
Stage 2, Gr1, LVSI positive
Stage 2, gr2-3, LVSI any

Tx: Adjuvant EBRT

22
Q

How is a high risk endometrial cancer defined

A

Stage 3-4A endometroid cancer, with no residual disease
Stage ≥1b, non-endometriod
Stage ≥1b, endometrioid, but p53mut

Tx: Sequential chemotherapy and EBRT
Or concurrent CRT followed by Cht

23
Q

What RT regimen is given for primary RT to the endometrium

A

Phase 1 (45Gy/25#) then phase 2 as brachytherapy / Dobbie (7Gy/1#)
Or phase 1 (45Gy/25#) followed by EBRT (20Gy/10#) boost to macroscopic disease
Or SIB (60Gy/25#) to tumour with 45Gy/25# to pelvis

24
Q

What brachytherapy dose is given post H+BSO to intermediate risk endometrial cancer

A

21Gy/3# to vaginal vault to reduce risk of local recurrence (15% to 2%)

Prescribed to 0.5cm depth

25
Q

What volumes are included for adjuvant RT for an endometrial cancer

What is the CTV-PTV margin

A

CTV1 - parametrium and top 2.5cm of vagina
CTV2 - nodal elective volume - Inguinal, int/ext iliacs, obturator and pre-sacral nodes.
Planned from L5/S1 to approx femoral heads, where ext iliacs leave pelvis

PTV1 -CTV1 + 10mm
PTV2 - CTV2 + 8mm

26
Q

How is metastatic low vol/indolent endometrial cancer managed

A

Consider hormonal treatment only - tamoxifen / AI / medroxyprogesterone (Megace)

27
Q

How is metastatic higher vol / non-indolent endometrial cancer managed

A

Assess MMR / MSI status

dMMR
1st line - dostarlimab/carboplatin/paclitaxel
2nd line - dostarlimab or pembro if not received 1st line

pMMR:
1st line - carboplatin (AUC5)/paclitaxel (175mg/m2), or single agent doxorubicin or paclitaxel if Pt-ChT not suitable

2nd line - pembro/lenva if pMMR

28
Q

What is the response rate of metastatic endometrial cancer to megace
What is the side effect

A

20-30%
Main side effect is cardiac toxicity

29
Q

What is the management of locally recurrent endometrial cancer

A

Re-biopsy if possible, repeat imaging and staging

If no RT previously -> EBRT +/- BT
If previous BT only -> EBRT
If prev EBRT -> surgery if amenable, or systemic treatment

30
Q

What 3 types of uterine sarcoma are most common

A

Leiomyosarcoma - high local recurrence rate
Endometrial stromal sarcoma
Carcinosarcoma - high risk, all treated with surgery, chemo, RT, vault brachy

31
Q

How is an endometrial leiomyosarcoma treated

What is the prognosis

A

Surgery - TAH only, as it doesn’t metastasise to ovaries
Adj ChT & RT

For advanced disease, treat with ifosfamide/doxorubicin or gemcitabine/docetaxel

OS 15-25%
Stage I & II have 5-yr survival rate 40-70%

32
Q

How is an endometrial stromal sarcoma treated

A

Surgery - TAH & BSO
Tend to be very hormone sensitive
1st line systemic treatment - AI or progestogen (not tamoxifen)
2nd line - ifosfamide

33
Q

How is an endometrial carcinosarcoma treated

A

Surgery, ChT, RT, BT
treat with carboplatin as they behave more like endometrial adenocarcinomas than sarcoma

FRCR2 (38 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions